CD274 and neoplasm: It is generally accepted that PD‐L1 is highly expressed in tumors, and the binding of PD‐L1 to PD‐1 on T cells inhibits tumor immunity by suppressing the transcription of genes and cytokines required for T‐cell activation, enabling tumors to escape T‐cell surveillance.